KK
NVCR icon

KLP Kapitalforvaltning’s NovoCure NVCR Stock Holding History

KLP Kapitalforvaltning’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348K Hold
23,000
– – ﹤0.01% 1672
2026
Q1 		$251K Hold
23,000
– – ﹤0.01% 1731
2025
Q4 		$297K Hold
23,000
– – ﹤0.01% 1683
2025
Q3 		$297K Hold
23,000
– – ﹤0.01% 1659
2025
Q2 		$409K Buy
23,000
+1,400
+6% +$24.4K ﹤0.01% 1459
2025
Q1 		$385K Hold
21,600
– – ﹤0.01% 1443
2024
Q4 		$644K Buy
+21,600
New +$457K ﹤0.01% 1219

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

KLP Kapitalforvaltning's NVCR Position: Q2 2026 in Review

KLP Kapitalforvaltning held its NovoCure (NVCR) position steady in Q2 2026 at 23,000 shares worth $348K. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

KLP Kapitalforvaltning first reported a position in NVCR in Q4 2024 and has held it in 7 quarters since. The position peaked at $644K in Q4 2024. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • KLP Kapitalforvaltning held 23,000 shares of NovoCure worth $348K as of Q2 2026.
  • KLP Kapitalforvaltning left its NovoCure share count unchanged in Q2 2026.
  • NovoCure made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1672 holding.
  • KLP Kapitalforvaltning first reported a position in NovoCure in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's NovoCure position peaked at $644K in Q4 2024.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.